arrow
A

André M. Siqueira

infectiology national institute
H指数:49
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasmodium falciparum Parasites With Histidine-Rich Protein 2 (pfhrp2) and pfhrp3 Gene Deletions in Frontier Endemic Regions of Brazilian Amazon

具有组氨酸富集蛋白2(pfhrp2)和pfhrp3基因缺失的<i>Plasmodium falciparum</i>寄生虫在巴西亚马逊前沿流行地区的分布

2026-09-300
OAAI
Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine

单剂量四价布他丹登革热疫苗的长期疗效和安全性

2026-03-040
PRE
Assessment of exertional capacity using the six-minute step test in COVID-19 survivors six months after hospitalization: a prospective observational study in Paraíba, Brazil

对巴西帕拉伊巴州新冠康复者出院后6个月使用6分钟台阶试验评估运动能力:一项前瞻性观察研究

2026-03-040
OAAI
Dengue virus genetic diversity in unvaccinated and vaccinated dengue-infected individuals: an observational analysis of the Butantan-DV phase 3 trial in Brazil

登革病毒在未接种疫苗和接种疫苗的登革热感染者中的遗传多样性:巴西Butantan-DV三期试验的观察性分析

2025-11-290
OAAI
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis

使用系统综述和个体患者数据Meta分析,对伯氨喹剂量在间日疟中的疗效、耐受性和安全性进行自动化报告

2025-11-140
OAAI
Evaluation of the Diagnostic Accuracy of the Quantitative Point-of-Care SD Biosensor Standard G6PD Test for Assessment of G6PD Deficiency in Infectious Diseases

评估定量即时检测SD Biosensor标准G6PD试验对感染性疾病中G6PD缺乏症诊断准确性的评价

2025-11-010
OAAI
TIMP-2 as a Potential Indicator of Persistent Arthralgia in Chikungunya: Evidence From a Brazilian Cohort Study

TIMP-2 作为基孔肯雅热持续性关节痛的潜在指标:来自巴西队列研究的证据

2025-10-140
OAAI
Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)

登革热临床试验核心结局测量集:一项国际德尔菲共识研究(DEN-CORE)

2025-10-070
PRE
Towards Malaria Elimination: A Nationwide Case-Control Study to Assess Risk Factors for Severe Malaria-Related Deaths in Brazil

迈向疟疾消除:一项全国性病例对照研究,用于评估巴西严重疟疾相关死亡的风险因素

2025-09-010
OAAI
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) in Brazilian healthcare professionals: The PROFISCOV trial

灭活全病毒SARS-CoV-2疫苗(CoronaVac)在巴西医疗保健专业人员中的有效性和安全性:PROFISCOV试验

Vaccine
IF3.5
2025-07-310
PRE
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil

Butantan-DV在2-59岁参与者中的疗效和安全性: 来自巴西的双盲,随机,安慰剂对照,3期,多中心试验的结果

2024-11-012
PRE
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults
2024-02-0147
PRE
Challenges of acute febrile illness diagnosis in a national infectious diseases center in Rio de Janeiro: 16-year experience of syndromic surveillance
2023-04-035
OAAI
Serum biomarkers associated with SARS-CoV-2 severity
2022-09-2620
OAAI
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study
2021-09-0198
OAAI
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study)

在巴西亚马逊地区的常规间日疟诊断单位中实际实施G6PD缺乏症筛查定性测试 (SAFEPRIM研究)

2021-05-1812
OAAI